Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma

Overview of attention for article published in Drug Design, Development and Therapy, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 1 news story.

Strong quarterly results with disappointing Zeal 1 and 2 data. Common problem of DP2 antagonists in severe asthma.